Mehar Pharmaceuticals Private Limited
About Mehar Pharmaceuticals Private Limited
Data last updated:
Mehar Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 January 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U33112CH1998PTC020919. Its GSTIN is 04AACCM9331K1ZF (Chandigarh).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹3.26 Lakh. It is led by directors Sonaal Nurpuri (Managing Director) and Monica Nurpuri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 8662nd Floor Manimajra, Chandigarh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.12 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹1.84 Lakh (net margin 7.6%) and EBITDA of ₹5.56 Lakh (EBITDA margin 23.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mehar Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressSCO 8662nd Floor Manimajra, Chandigarh, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mehar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mehar Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mehar Pharmaceuticals Private Limited, buy the company report.
Financials of Mehar Pharmaceuticals Private Limited
FY 2025 filings availableMehar Pharmaceuticals Private Limited reported revenue of ₹24.12 Lakh (up 46% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 46% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.1% | ||||
| Net Profit Margin | 7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mehar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mehar Pharmaceuticals Private Limited
Mehar Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monica Nurpuri | Director | 07 Jan 1998 | 28 Years 9 Months | Current |
| Sonaal Nurpuri | Managing Director | 07 Jan 1998 | 28 Years 9 Months | Current |
Auditor
Mehar Pharmaceuticals Private Limited is audited by MALHOTRA RAJIV & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MALHOTRA RAJIV & CO | FY 2022 | 024854N |
Shareholding
The shareholding of Mehar Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mehar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mehar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mehar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mehar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCM9331K1ZF | Chandigarh | Active | 21 Jul 2017 |
To see the full GST registrations and return filing status of Mehar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mehar Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Monica Nurpuri was appointed as Director on 07 Jan 1998.
Frequently asked questions
Mehar Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 January 1998 (28+ years old) and is registered under CIN U33112CH1998PTC020919.
Mehar Pharmaceuticals has 2 current directors:
- Sonaal Nurpuri - Managing Director
- Monica Nurpuri - Director
The latest financial statements of Mehar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mehar Pharmaceuticals is 04AACCM9331K1ZF, registered in Chandigarh.
The CIN (Corporate Identification Number) of Mehar Pharmaceuticals is U33112CH1998PTC020919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mehar Pharmaceuticals was incorporated on 07 January 1998, making it 28+ years old. It is registered with the Registrar of Companies, Chandigarh.
Monica Nurpuri was appointed as Director on 07 Jan 1998. Sonaal Nurpuri was appointed as Managing Director on 07 Jan 1998.
The registered office of Mehar Pharmaceuticals is at SCO 8662nd Floor Manimajra, Chandigarh, India.
Mehar Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Mehar Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.